Zebrafish as an Emerging Model for Dyslipidemia and Associated Diseases-Reference-Cited by-同舟云学术

Zebrafish as an Emerging Model for Dyslipidemia and Associated Diseases

Published:2021 Issue:1 Volume:10 Page:42
ISSN:2287-2892
Container-title:Journal of Lipid and Atherosclerosis
language:en
Short-container-title:J Lipid Atheroscler

Author:

Ka Jun¹^ORCID,Jin Suk-Won¹²^ORCID

Affiliation:

1. Cell Logistics Research Center and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.

2. Yale Cardiovascular Research Center and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Funder

Korean Ministry of Trade, Industry, and Energy

National Research Foundation of Korea

Publisher

Korean Society of Lipidology and Atherosclerosis

Link

https://e-jla.org/pdf/10.12997/jla.2021.10.1.42

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models;Journal of Ethnopharmacology;2025-01

2. Loss ofasgr1aleads to the secretion of excess dietary cholesterol in zebrafish;2024-06-29

3. Directly Measuring Atherogenic Lipoprotein Kinetics in Zebrafish with the Photoconvertible LipoTimer Reporter;2024-05-31

4. Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05

5. Long-Term Supplementation of Royal Jelly (Raydel®) Improves Zebrafish Growth, Embryo Production and Survivability, Blood Lipid Profile and Functionality of Vital Organs: A 72-Weeks’ Consumption Study;Pharmaceuticals;2024-03-01